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The analysis of the clinical and HLA profiles of 99 patients with Reiter’s syndrome is 
reported. Antigen HLA-B27, which has previously been firmly associated with Reiter’s 
syndrome, predisposes patients to develop disease features which reflect articular involve- 
ment. The HLA haplotype A2, B27 was found to be at an elevated frequency in our Rei- 
ter’s syndrome sample, and the latter two antigens are also associated with a general in- 
crease in disease severity. Conversely, antigen BW35 appears to be protective against 
certain features of the syndrome. Patients with certain antigenic profiles (namely A2 and 
A3 together with B27) tend to develop certain syndrome manifestations earlier in the 
course of the disease than those with other antigens. 
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The major diagnostic criteria of Reiter’s 
syndrome (RS) are arthritis, ophthalmitis, 
urethritis, and mucocutaneous lesions. A 
definite diagnosis is based upon arthritis of 
peripheral joints plus at least two other 
members of the tetrad. The arthritis typi- 
cally involves the feet and knees and has 
a non-symmetric distribution. In addition, 
several minor criteria such as fever, diar- 
rhea, weight loss, pain in the sacroiliac 
joints or spine and heel involvement have 
aided in diagnosis during acute attacks 
(Good 1977). Features that may emerge 
during long-term follow-up are: radio- 
graphic signs of sacroiliitis with or without 
chronic back pain, classical ankylosing spon- 
dylitis, heel spurs, aortitis, chronic psoriasis 
vulgaris, and chronic involvement or resid- 
ual deformity of peripheral joints. Neuro- 
logical involvement (Good 1974) and iritis 
are features during either the acute or 
chronic phase of the disease. 
The HLA antigen B27 has a frequency 
of 65 %-lo0 % (Svejgaard & Ryder 1977) 
in various series of patients with RS. This 
frequency may be compared to a frequency 
of approximately 10 % in a normal popula- 
tion. Although it has been reported that 
B27 negative patients with reactive arthritis 
usually have a milder form of disease (Ah0 
et al. 1974), no clear phenotypic hetero- 
geneity between B27 negative RS patients 
and B27 positive patients has been defini- 
tively established. 
This communication reports the results 
of the analysis of the clinical and HLA 
antigenic profiles of 99 patients with RS. 
We have sought to determine whether cer- 
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tain clinical features of RS are predicted by 
any HLA-A,-B or combinatio,n of A and B 
antigens, and whether any of these features 
tend to cluster together in a particular 
group of individuals. 
Materials and Methods 
Ninety-nine unrelated male patients, 86 
Caucasians and 13 blacks, with clinical diag- 
noses of RS were encountered at the Ann 
Arbor Veterans Administration or Univer- 
sity of Michigan Medical Centers from 1 
July 1974 to 31 December 1977. X-rays of 
the sacroiliac joints were available in 89 
and heel X-rays in 63. 
Sixty-one definite cases of RS presented 
with peripheral arthritis plus two or more 
of the other major criteria (ophthalmitis, 
urethritis, and mucocutaneous lesions). In 
addition, 36 patients with typical peripheral 
arthritis and non-specific urethritis only 
were classified as strongly probable RS and 
added to the study group. Two individuals 
without a definite history of peripheral 
arthritis were included. One individual had 
heel pain, conjunctivitis, back pain and 
sacroiliitis, while the second patient pre- 
sented with urethritis, sternoclavicular ar- 
thritis, balanitis and oral mucosal lesions. 
Ascertainment for KS was, therefore, sub- 
stantially complete for the study period. 
Eighteen patients were encountered only 
during an acute attack; 81 patients were 
followed 18 months or more after disease 
onset. Patient records were screened for 
features of acute attacks or follow-up fea- 
tures listed in Table 2. The approximate 
years of initial occurrence of each of the 
acute and late features of the disease were 
determined from available records, written 
questionnaires, and/or patient interviews. 
Blood specimens for tissue typing were 
obtained from 99 probands. One hundred 
forty-nine siblings, parents and/or children 
of 43 of these probands also contributed 
blood specimens to aid in the determination 
of proband haplotypes. Leukocytes for HLA 
typing are separated from whole blood 
samples by a modification of the method 
of Boyum (1968). HLA typing is performed 
by a minor modification of the standard 
NIH cytotoxicity technique (Amos 1976). 
The associations between antigens, be- 
tween symptoms and between antigens and 
symptoms were explored using the Cochran/ 
Mantel-Haenzel test (Landis 1979). This 
method was used to compute the average 
partial associations within tables stratified 
according to the length of exposure of the 
patient to clinical investigation. The as- 
sociations within three levels of exposure 
(years); 1-13, 13-26, and 27 and greater, 
were considered. A test of heterogeneity of 
association among levels was taken as 
evidence for a bias of length of exposure 
on the association. Only those associations 
which were not significantly heterogeneous 
across exposure classes are reported in 
Tables 3-5. 
Results 
Table 1 contains the observed and expected 
number of 7 first and 13 second locus anti- 
gens in the sample studied. We have HLA 
typed a sample of 202 normal volunteers 
for 20 antigens of the A and B locus. The 
percentage of blacks included in our con- 
trol sample corresponds with the percentage 
of blacks in the RS sample. 
Those antigens which occur at a relative 
frequency 2 0.13 were selected for studies 
of association with the clinical features of 
the syndrome. Those antigenic combinations 
which occur 11 or more times in our 
sample, plus the A9-B27 combination which 
contains two antigens with relatively high 
frequencies, were selected for the studies of 
clinical associations. The frequencies of 
combinations of these antigens in the patient 
sample did not differ from expected fre- 
quencies for a normal population. 
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Table 1 
Frequency of HLA antigens in Reiter's syndrome sample as compared with frequency 
in a normal population 




o bs antigen X2 # x 2 ( i d f )  exp 
# 
obs 
anti g o n 
1 23 30 1.633 5 3 8 3.125 
2 54 50 0.320 7 11 23 6.260 
3 28 21 4.666 8 14 17 0.529 
9 13 18 1.388 12 10 25 9.000 
10 9 13 1.230 13 1 5 - 
11 6 11 2.272 14 7 9 0.444 
28 5 7 0.571 15 3 12 6.750 
16 2 6 2.666 
17 8 13 1.923 
18 2 6 2.666 
27 76 8 578.000 
35 21 26 0.961 
40 7 7 0.000 
* *  Statistically significant at the 0.01 level of probability. 
Table 2 
Frequency and time of appearance of RS features 
Frequency of Response 
Yes No Maybe Before & During After XZldf 
Appearance of RS manifestations in 
cases relative to RS onset 
A. Oral mucous membrane and 
cutaneous involvement 
(1) Mouth lesions 
(2) Balanitis 
(3) Skin or nail involvement 
(4) Chronic skin involvement 
or psoriasis 
Average % (24.25) 
8. Other non-articular manifestations 






Average % (41.83) 
C. Articular manifestations 
(1) Heel pain 
(2) Peripheral arthritis 
(3) Acute back pain 
(4) Chronic peripheral joint involvement 
(5) Chronic back pain 
(6) Ankylosing spondylitis 
Average % (55.5) 
22 75 2 
38 60 1 
27 71 1 
10 88 1 
62 32 5 
24 75 0 
88 11 0 
47 52 0 
8 88 2 
22 76 0 
46 50 3 
97 2 0 
91 7 1 
30 57 11 
51 41 6 

































Average % of all manifestations - 41 
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Family studies provide 72 true haplo- 
types for 36 RS patients. Of the 37 haplo- 
types represented, only one, A24327 ap- 
pears more than four times. This haplotype 
appears 18 times rather than the seven 
times expected based on the antigenic fre- 
quencies of A2 and B27 in this sample. This 
deviation from expectation is significant at 
the 0.05 level of probability. 
Table 2 gives the frequency of each of the 
clinical features studied. The features have 
been grouped as follows: Group A - ba- 
lanitis and oral mucous membrane and 
cutaneous and nail involvement. Allowing 
for regional differences due to the presence 
of saliva or mucous, the rnucocutaneous 
lesions share the histopathology of pustular 
psoriasis, namely acanthosis, elongated rete 
pegs, microabscesses and hyperkeratosis 
(Kulka 1962), Group B - non-articular 
manifestations which do not share a com- 
mon pathology and Group C - articular in- 
volvement. All of the features included in 
this group have in common either acute or 
chronic joint or heel pain. The frequencies 
of the disease manifestations listed in Table 
2 serve to describe the clinical properties 
of the syndrome. The distribution of the 
reported appearance of a disease manifesta- 
tion with respect to disease onset is also 
presented. The onset of the disease was 
defined as the time of appearance of pe- 
ripheral arthritis or heel pain. For those 
cases where a test of a uniform distribution 
is reasonable, iritis, skin or nail involvement 
and mouth lesions fail to be significantly 
heterogeneous with respect to the onset of 
disease. 
It is relevant for predictive purposes to 
know whether any of the seven selected 
HLA antigens or five antigenic combina- 
tions predispose an individual to develop his 
disease manifestation early or late in life. 
Taking onset of peripheral arthritis as the 
time of onset for RS, patients developing 
the syndrome before and after 30, the 
median sample age, had similar frequencies 
of all antigens and antigenic combinations 
except for antigen A9, which was associated 
with early onset (P = 0.05). 
The associations of the clinical features 
within clusters and between clusters after 
applying the Cochran/Mantel-Haenzel cor- 
rection for heterogeneity of length of expo- 
sure are found in Table 3. Table 4 shows 
the associations between the selected HLA 
Table 3 
A summary of the statistically significant positive associations between syndrome features 
WITHIN CLUSTERS 
Oral mucous membrane and cutaneous involvement Mouth lesions Chronic skin involvement 
(psoriasis) 
Skin or nail involvement f *  
Articular manifestations Heel pain Ankylosing Chronic back pain 
spondylitis 
Chronic peripheral joint involvement .. 
Chronic back pain 
Bilateral X-ray changes * *  
I *  
BETWEEN CLUSTERS 




* = Probability of observing a larger maximum likelihood test criterion by chance = a = 0.05 
* *  = Probability of observing a larger maximum likelihood test criterion by chance = a = 0.01 
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Table 4 
Association of occurrence of features and appearance of features before, during or after 
onset of disease with selected A and 6 locus antigens 
Antigens 
A Locus B Locus 
0 27 W35 Clinical features 1 2 3 9  
~ 
Oral mucous membrane and cutaneous involvement 
0'0 Mouth lesions 
Other non-articular manifestations 
Fulminant onset, fever or weight loss i 
6 Diarrhea 
lritis 
Aortitis (no aortitis in anyone before onset) 
i 
Articular involvement 
i ' d  Heel pain (no heel pain in anyone before onset) 
Acute back pain 
Chronic back pain 
Ankylosing spondylitis (no AS in anyone before onset) 
6 0  
0' 0 
.. + b  
I f  + 
+ .  + 
* Probability of observing a large maximum likelihood test criterion by chance = n = 0.05 
* *  Probability of observing a large maximum likelihood test criterion by chance = a = 0.01 
After 0 ;  During 0; Before 0. + Positive association; - Negative association 
antigens and clinical features after the 
Mantel-Haenzel correction has been applied. 
Individuals with antigen B27 are more 
likely to develop articular features in addi- 
tion to their acute peripheral joint involve- 
ment. Antigen A1 and fulminant onset with 
fever or weight loss, and antigen B8 and 
chronic back pain are also associated. A 
negative association of ankylosing spon- 
dylitis (AS) and antigen BW35 is shown. 
The results of an analysis of the relationship 
of age at onset of various clinical mani- 
festations and HLA antigenic types, as 
shown in the same table, indicate that pa- 
tients with antigens A l ,  2 or 3 or BW3.5 are 
heterogeneous in the time of occurrence of 
certain manifestations. 
Table 5 gives the same type of analysis 
of associations for pairs of antigens and 
clinical features as is found in Table 4 for 
single antigens. The associations which 
remain consistent over the whole observa- 
tion time range are those between the anti- 
genic combination A2, B27 and heel pain, 
acute back pain and chronic peripheral 
joint involvement; antigens A1 and B27 and 
skin or nail involvement and chronic back 
pain and antigens A1 and B8 with chronic 
back pain. The antigen pairs A l ,  B27 and 
A2, B27 are also associated with hetero- 
geneity in time of appearance of disease 
features. It was established that only anti- 
gens A1 and B27 increase the risk of devel- 
oping a larger total number of clinical fea- 
tures (11-14) of RS when found separately 
or in combination. No other antigens or 
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Table 5 
after onset of disease with selected A and B locus antigenic pairs 
Association of occurrence of features and appearance of features befox,  during and 
Clinical feature 1,27 2,27 3,27 2,35 1,8 
Oral mucous membrane and cutaneous involvement 
Skin or nail involvement 
Other non-articular manifestations 




Acute back pain 
Chronic peripheral joint involvement 





. I  + 
i 
* Probability of observing a large maximum likelihood test criterion by chance = CT = 0.05 
* *  Probability of observing a large maximum likelihood test criterion by chance = u = 0.01 
After 0 ;  During 9; Before 0. + Positive association; - Negative association 
antigenic co'mbinations are predictive of the 
number of clinical features which develop 
in these patients. 
Discussion 
Our data have enabled us to draw certain 
conclusions about the inter-relationships be- 
tween the clinical features of RS and their 
heterogeneity with respect to certain HLA-A 
and -B locus antigens and combinations of 
these antigens. As one would anticipate 
from consideration of the literature, the 
deviation of the observed frequency of B27 
antigen from its expectation in normals 
( X S , , ,  = 578.00) is the largest contributor 
to the overall poorness of fit (XZlldf = 
612.324) of the data to the frequencies ex- 
pected in a random sample of healthy in- 
dividuals. The excess of B27 is compen- 
sated for by deficiencies of all other B locus 
antigens tested. The elevated frequency of 
the A2, B27 haplotype in RS is in agree- 
ment with the data of Terasaki & Mickey 
(1975). Even though the A2, B27 haplo- 
type exceeds the expected frequency, the 
simple presence of these two antigens in a 
single individual does not appear at  an ele- 
vated frequency. 
Our arrangement of clinical features into 
clusters was made to be consistent with 
clinical diagnostic procedure. The groupings 
of clinical features were those which a 
physician might generate when presenting a 
clinical diagnosis. A dichotomy in frequency 
of occurrence among these clustered char- 
acteristics is apparent. Articular manifesta- 
tions occur on the average in more than half 
of RS patients (56 %), while single features 
of oral mucous membrane involvement are 
present in less than 25 % of all patients. 
Clearly there are two separate groups of 
disease symptoms in this sample, those 
which are most common and those which 
are less common. More than 40 % of the 
test population also show manifestations 
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which are outside of these two groups 
(classed as other non-articular manifesta- 
tions). 
We found considerable heterogeneity in 
time of reporting of disease features in 
relationship to disease onset. Mucous mem- 
brane and other non-articular manifestations 
tended to occur more often concurrently 
with the disease onset, while the features of 
articular involvement varied with respect to 
time of onset. Heel pain and acute back 
pain appeared more often at onset, while 
chronic peripheral joint involvement, chron- 
ic back pain and AS tended to appear after 
the onset of the disease. In this study, most 
features occurred acutely either at or after 
disease onset. 
The large amount of clinical data avail- 
able from this study enables us to ask which 
disease features tend to aggregate in indi- 
viduals. Some features are yet to appear in 
those individuals who have been observed 
for short periods, since correlations between 
features made before the Mantel-Haenzel 
A 
correction was applied differed markedly 
from the correlations outlined in Table 3. 
The highest degree of association was shown 
to occur within the articular manifestations 
cluster. Chronic peripheral joint involve- 
ment was associated only with heel pain, 
and, as expected, chronic back pain and 
bilateral sacroiliac X-ray changes were as- 
sociated with AS. It appears, therefore, that 
features of articular involvement may be 
separated into two groups; those involving 
the spine and those involving the periphery. 
The association between skin or nail in- 
volvement and chronic skin involvement 
was the strongest (P(O.0003) of all asso- 
ciations and certainly unlikely to be a 
chance association. Skin or nail involvement 
and mouth lesions, which are significantly 
associated, also have a common pathophys- 
iology. Unexpected associations across clus- 
ters were between aortitis and heel pain and 
chronic skin involvement. 
Not only is antigen B27 a predictor of 
disease occurrence, but it also predisposes 
B 
( . l i ronic  Rack P a i n  0 A c u t e  Rack Pain 
1 1 1 1 1 1 1 1 1 1  S k i n  and N a i l  I n v o l v e m e n t  
............. HLA - A 1  R ? i  
............. ............. ............. ............. ............. ............. ............. 
__ -
C h r o n i c  P e r i p h e r a l  . J o i n t  I n v o l v e m e n t  - 
.............. .............. .............. .............. .............. :::::::::::::: HLA - A 2  82 i .............. 
Fig. 1. Associations of syndrome manifestations and antigen pairs in Reiter's syndrome. 
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an RS patient to heel pain and acute back 
pain (Table 4). When both antigens A2 and 
B27 are present, there is a tendency to 
chronic peripheral joint involvement (Table 
5) ,  not evident when B27 or A2 occurs in- 
dependently. However, patients with A2 
tend to acquire articular involvement early 
in the disease course. 
Although antigen A1 is not associated 
with chronic back pain or skin and nail 
involvement, it shows an association with 
these characteristics when antigen B27 or 
B8 (in the case of chronic back pain) is 
present as well. Conversely, although anti- 
gen A1 is associated with fulminant onset of 
the disease with fever or weight loss, no 
particular B locus antigen is related to in- 
creased likelihood of development of these 
characteristics. Patients with antigen A1 
appear to have relatively late development 
of RS. 
Of particular interest is the negative as- 
sociation between antigen BW35 and AS. 
It appears that this antigen confers a pro- 
tective effect against the development of AS 
secondary to RS, and may account for the 
reduced severity of RS in blacks (Good 
1979) who have a high frequency of this 
antigen. 
The Venn diagrams in Figure 1 give a 
visual summarization of the interrelation- 
ships of two cross cluster associated fea- 
tures and the antigen pair A l ,  B27, and of 
three within cluster associated features and 
antigen pair A2, B27. The cross cluster as- 
sociation is shown in Figure 1-A. Sixteen 
of 41 individuals with chronic back pain 
are HLA-A1, B27. Ten of these individuals 
also have skin or nail involvement. There 
are six individuals with skin or nail invoIve- 
ment who do not report chronic back pain. 
Interestingly, these individuals also lack the 
A l ,  B27 combination. Only 4 of the 20 
individuals who have A l ,  B27 do not have 
chronic back pain and skin or nail involve- 
ment. 
As can be seen in Figure 1-B, the intra- 
cluster relationship of acute back pain, 
chronic joint involvement and heel pain 
with the antigenic combination A2, B27 is 
even more pronounced. All 43 RS patients 
with A2, B27 have had acute back pain, 26 
of the 43 have heel pain and 21 of the 43 
have chronic joint involvement. There are 
16 patients who share all three clinical 
characteristics and the antigenic combina- 
tion. These relationships are all independent 
of length of time observed. 
It has frequently been hypothesized that 
HLA antigenic profile might influence dis- 
ease development and severity, particularly 
in those multifaceted diseases in which a 
clear association with one HLA antigen 
has been shown. We have demonstrated 
that HLA antigenic profile does not show 
random distribution with some clinical 
manifestations of RS. HLA analysis may 
therefore lead to the identification of dis- 
ease subsets with different phenotypic ex- 
pression, the consequence of genetic-envi- 
ronmental interactions. These data are con- 
sistent with the hypothesis that alleles at the 
HLA locus modify factors primarily respon- 
sible for the onset or course of RS. Ulti- 
mately the clinician may be able to design 
appropriate therapeutic regimens based on 
early manifestations and HLA type. 
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